Story · Medicine & Biotech

Aakash Desai: TROP2 NMR as a Predictive Biomarker for Datopotamab Deruxtecan in NSCLC

1 outlet · first reported by OncoDaily on

Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on X: “TROP2 NMR : TROPION-Lung01 nsq NSCLC, no AGAs (n=221) Dato-DXd, NMR+ vs NMR-: mPFS 7.2 vs 4.0 mo, (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Aakash Desai: TROP2 NMR as a Predictive Biomarker for Datopotamab Deruxtecan in NSCLC

    Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on X: “TROP2 NMR : TROPION-Lung01 nsq NSCLC, no AGAs (n=221) Dato-DXd, NMR+ vs NMR-: mPFS 7.2 vs 4.0 mo,

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.